Horizon 2020 BRUNO MOURENZA. Horizon 2020 Punto di Contatto Nazionale SALUTE

Transcription

1 Horizon 2020 BRUNO MOURENZA Horizon 2020 Punto di Contatto Nazionale SALUTE

2 Three Priorities What s New? Industrial leadership Excellent science Societal challenges A single programme More innovation from research to retail Focus on societal challenges Simplified and broader access 2

3 Struttura del programma Excellent Science European Research Council Frontier research by the best individual teams Future and Emerging Technologies Collaborative research to open new fields of innovation Marie Skłodowska Curie actions Opportunities for training and career development Research infrastructures (including e-infrastructure) Ensuring access to world-class facilities Industrial Technologies Leadership in enabling and industrial technologies ICT, nanotechnologies, materials, biotechnology, manufacturing, space Access to risk finance Leveraging private finance and venture capital for research and innovation Innovation in SMEs Fostering all forms of innovation in all types of SMEs Societal Challenges Health, demographic change and wellbeing Food security, sustainable agriculture, marine and maritime research & the bioeconomy Secure, clean and efficient energy Smart, green and integrated transport Climate action, resource efficiency and raw materials Inclusive, innovative and reflective societies Security society European Institute of Innovation and Technology (EIT) Spreading Excellence and Widening Participation Science with and for society Joint Research Center (JRC) 3

4 IMPLEMENTAZIONE Work ProgrammesH2020 STRATEGIC PROGRAMME: A multi-annual approach (3 years) to help applicants plan ahead. (note: this could be subject to the vote of Programme Committee) WORK PROGRAMMES: 3 Work Programmes (biannual) during the course of H2020 and 1 final Work Programme for the last year to bridge to the next programme after

5 H2020 Work Programmes: Multi-annual Programming Strategic Programme Work Programme 1 Work Programmes mirror the strategic programme and are updated over the same 2-year cycle Strategic Programme Work Programme 2 Strategic programmes: short documents outligning priorities over 3 years, updated every two years Strategic Programme Work Programme 3 Work Programme 4 Smaller and continuous updates to respond to unexpected developments Calls published on basis of WP Ad hoc financing decision Calls published on basis of WP Ad hoc financing decision Calls published on basis of WP Ad hoc financing decision Calls published on basis of WP 5

6 1. HEALTH, DEMOGRAPHIC CHANGE AND WELLBEING 6

7 The Horizon 2020 societal challenge of Health, Demographic change and Wellbeing (SC1) for the years 2014 and 2015 Includes 36 topics in the personalising health and care focus area call, and 15 topics in the co-ordination activities call. The total budget available is approximately EUR 1.20bn. Topics in the call are divided into 7 areas. Societal challenge 1 is also implemented by the Innovative Medicines Initiative (IMI), the European and Developing Countries Clinical Trials Partnership (EDCTP), the Active and Assisted Living programme (AAL) and the European Innovation Partnership on Active and Healthy Ageing (EIP-AHA). Many topics will be evaluated in two stages. Exceptions to the two stage approach include a number of close to market type topics, including those which make use of the SME instrument. The 2014 topics deadlines are as follows: Two stage calls: Stage 1 11 March 2014 Stage 2 19 August 2014 One stage calls: 15 April 2014 The 2015 topics deadlines are as follows: Two stage calls: Stage 1 14 October 2014 Stage 2 24 February 2015 One stage calls: 21 April

8 Understanding the call topics: example 'PHC ' 'Specific challenge' 'Scope' 'Expected impact' 'Type of action' 8

9 Where are we now in health? Call for Personalizing Health and Care Understanding health, ageing and disease 1.2. Effective health promotion, disease prevention, preparedness and screening 1.3. Improving diagnosis On content? 1.4. Innovative treatments and technologies 1.5. Advancing active and healthy ageing 1.6. Integrated, sustainable, citizen-centred care 1.7. Improving health information, data exploitation and providing an evidence base for health policies and regulation IMI, AAL, EDCTP cutting across 9

10 Call for Co-ordination activities EIP on AHA European Innovation Partnership on Active and Healthy Ageing 1.2. JPI Joint Programming Initiative More Years and Better Lives 1.3. European Reference Networks: Efficient network modelling and validation 1.4. Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes 1.5. ERA-NETs - Synergies between JPND (Neurodegenerative Diseases) and H Cancer Research - Brain related diseases - Systems medicine for clinical needs research - Rare Diseases research implementing IRDiRC objectives 10

11 Rules of Participation 11

12 SINGLE SET of RULES Covering all research and innovation programmes, initiatives and funding bodies (art. 185 and art. 187 initiatives, EIT, ), but flexible to accommodate specificities where needed (through delegated acts) Coherent with the rules contained in the Financial Regulation (FR), but containing "derogations" EU FINANCIAL REGULATION 12

13 Legal entity participant (art.6)/ Eligibility for funding (art.9) WHO CAN PARTICIPATE? WHO CAN BE FUNDED? Any legal entity established in a MS, associated country* or third country JRC (Joint Research Centre) International organizations of European interest International organizations and entities established in third countries fulfilling the minimum conditions *Albania, Bosnia-Herzegovina, Croatia, FYR Macedonia, Iceland, Israel, Liechtenstein, Montenegro, Norway, Serbia, Switzerland, Turkey Any legal entity established in a MS, associated country or third country JRC (Joint Research Centre) ICPC countries International organizations of European interest International organizations and entities established in third countries no ICPC only in case is required by the WP/ bilateral agreement or if it s essential for the action Possibility of di Joint Call with third countries and international organization 13

14 ELIGIBILITY for FUNDING DEFINITIONS ANY NATURAL PERSON, OR ANY LEGAL PERSON CREATED UNDER THE NATIONAL LAW,COMMUNITY LAW OR INTERNATIONAL LAW, WHICH HAS LEGAL PERSONALITY LEGAL ENTITY NO LEGAL PERSONALITY IF REPRESENTATIVES HAVE THE CAPACITY TO UNDERTAKE LEGAL OBLIGATIONS ON BEHALF OF THE ENTITY AND OFFER GUARANTEES OF PROTECTION OF UNION S FINANCIAL INTERESTS EQUIVALENT TO THOSE OFFERED BY LEGAL PERSONS NEW N.A. NON-PROFIT LEGALENTITY... NON-PROFIT-MAKING LEGAL FORM OR LEGAL/STATUTORY OBLIGATION NOT TO DISTRIBUTE PROFITS TO ITS SHAREHOLDERS OR INDIVIDUAL MEMBERS 14

15 CONDITIONS for PARTICIPATION MINIMUM CONDITIONS For standard collaborative actions At least 3 legal entities, each established in different MS/AC For SME Instrument, programme co-fund, CSA 1 legal entity established in a MS/AC ADDITIONAL CONDITIONS To be set out in the Work Programme (i.e. number of participants, type of participants, etc.) 15

16 METHOD OF FUNDING (art.5) Research and Innovation action Innovation action Coordination and Support Actions Programme Co-funding Actions Pre-Commercial Procurement (PCP) Public Procurement of Innovative Solutions (PPI) PRIZES NEW NEW 16

17 TYPES of ACTIONS INNOVATION ACTION DEMONSTRATION ACTIVITY (REIMBURSED UP TO 50%) NEW INNOVATION ACTION ACTIVITIES DIRECTLY AIMING AT PRODUCING PLANS AND ARRANGEMENTS OR DESIGNS FOR NEW, ALTERED OR IMPROVED PRODUCTS, PROCESSES OR SERVICES...MAY INCLUDE PROTOTYPING, TESTING, DEMONSTRATING, PILOTING, LARGE-SCALE PRODUCT VALIDATION AND MARKET REPLICATION PHC : Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment -Single Stage (15 th April2014) - Budget:10millEUR -EU contribution: 2/3 mill EUR (70%) 17

18 PRIZES Recognition prizes (Nobel Prize, DG INFSO's "ICT Prize", )= recognition of scientific achievements already attained Inducement Prizes = competition which induce' to the achievement of a specific goal(ortieg Prize, Ansari X-Prize, ). 18

19 INNOVATION ACTION SPECIFIC PROCEDURES B. SME INSTRUMENT Implemented just by one Agency (EASME - Executive Agency for Small and Medium-sized Enterprises). Addressed to all kind of innovative SME s willing to growth, develop and internationalize. In general, Bottom-Up approach. Only SMEs allowed to apply for funding and support (1 SME or consortium of SMEs) 19

20 Oriented to the market: Close-to-Market activity; funded up to 70% or up to 100% if research activities are predominant. Societal challenges and LEIT Continuously open call with several cut-off dates per year: First cut-off for Phase 1 around June 2014; first cut-off for Phase 2 in autumn

21 21

22 SME Definition Engaged in an economic activity < 250 employees Annual turnover 50 Millions or annual balance sheet total 43 Millions Autonomous Definition: cts-figures-analysis/sme-definition/index_en.htm Guide to EU definition of SME: definition/sme_user_guide_it.pdf 22

23 SME INSTRUMENT Concept & Feasibility Assessment Idea to concept, risk assessment, technological & commercial feasibility Demonstration Market replication R&D Demonstration, prototyping, testing, market replication, scaling up, miniaturisation, research Commercialisation Quality label for successful projects, access to risk finance, indirect support Pre-Commercial Procurement SME windoweu financial facilities Idea continued support throughout the project Market 23

24 SME Instrument in H2020 Excellent Science European Research Council Frontier research by the best individual teams Future and Emerging Technologies Collaborative research to open new fields of innovation Marie Skłodowska Curie actions Opportunities for training and career development Research infrastructures (including e-infrastructure) Ensuring access to world-class facilities Industrial Technologies Leadership in enabling and industrial technologies ICT, nanotechnologies, materials, biotechnology, manufacturing, space Access to risk finance Leveraging private finance and venture capital for research and innovation Innovation in SMEs Fostering all forms of innovation in all types of SMEs Societal Challenges Health, demographic change and wellbeing Food security, sustainable agriculture, marine and maritime research & the bioeconomy Secure, clean and efficient energy Smart, green and integrated transport Climate action, resource efficiency and raw materials Inclusive, innovative and reflective societies Security society European Institute of Innovation and Technology (EIT) Spreading Excellence and Widening Participation Science with and for society Joint Research Center (JRC) 24

25 Phase 1: Concept and feasibility assessment Input: Idea/Concept: "Business Plan 1" (~ 10 pages) 10% budget 10% success SME Instrument Activities: Feasibility of concept Risk assessment IP regime Partner search Design study Pilot application etc % success Output: elaborated "Business plan 2" Phase 2: R&D, demonstration, market replication Input: "Business plan 2" plus description of activities under Phase 2 (~ 30 pages) 88% budget Activities: Development, prototyping, testing, piloting, miniaturisation, scaling-up, market replication, research Output: "investor-ready Business plan 3" Phase 3 = 2% budget Phase 3: Commercialisation Promote instrument as quality label for successful projects Facilitate access to private finance Support via networking, training, information, addressing i.a. IP management, knowledge sharing, dissemination SME window in the EU financial facilities (debt facility and equity facility) Possible connection to PPC (and PPI?) Lump sum: (5) M EC funding ~ 6 months ~ 12 to 24 months ~2 months evaluation ~4 months evaluation No direct funding 25

26 Criteria (art. 14) 3CRITERIAS Criterio 1 Excellence Criterio 2 Impact Criterio 3 Quality and efficiency of implementation Possibility of 2-Stages calls Excellence, unique criteria on ERC actions High importance of impact in the innovation action 26

27 SIMPLIFIED FUNDING METHOD REIMBURSEMENT RATES UP TO 100% FOR RESEARCH AND INNOVATION ACTIONS UP TO 70% FOR INNOVATION (NON-PROFIT ENTITIES UP TO 100%) AND PROGRAMME CO- FUND ACTIONS NEW 27

28 SIMPLIFIED FUNDING METHOD INDIRECT COSTS STANDARD FLAT RATE (20%) SPECIAL FLAT RATE (60%) SIMPLIFIED METHOD or ACTUAL INDIRECT COSTS FLAT RATE OF 25% OF TOTAL DIRECT COSTS, EXCLUDING SUBCONTRACTING, COSTS OF THIRD PARTIES AND FINANCIAL SUPPORT TO THIRD PARTIES NEW 28

29 Types of collaborative projects R&D projects Basic research, applied research, technology development and integration, and testing e validation on a small scale prototype in a laboratory or simulated environment Closetomarket projects Prototyping, testing, demostrating, piloting, large - scale product validation and market replication 29

30 Types of collaborative projects 30

31 Funding rates Cost Category Direct costs Indirect costs Flat rate Funding Research & Development: max. 100% Close-to-market actions: max. 70% Exception: Close-to-market actions for non-profit legal entities: max.100% Flat rate: 25% of total direct costs 31 Fit for Health,

32 CONTROLS and AUDITS EX POST AUDIT NEW UP TO FIVE YEARS AFTER THE END OF THE PROJECT LIMITED TO TWO YEARS AFTER THE PAYMENT OF THE BALANCE 32

33 OPEN ACCESS ONLINE ACCESS AT NO CHARGE TO THE USER to peer-reviewed scientific publications to research data SPECIAL CLAUSE 39 (SPECIFIC FOR FP7 THEMES: ENVIRONMENT, ENERGY, HEALTH, ICT, SSH, INFRASTRUCTURES, SIS) OBLIGATION TO PROVIDE OA, EITHER THROUGH THE GREEN OR GOLD WAY ALLOWED EMBARGOS: 6/12 MONTHS. OPEN ACCESS COSTS ELIGIBLE FOR REIMBURSEMENT NEW 33

34 Participant Portal and SEP: general overview of the system. Starting from the project proposal to the final report 34

35 Participant Portal general information The Participant Portal is the single entry point for electronic administration of EU-funded research and innovation projects, and hosts the services for managing your proposals and projects throughout their lifecycle. 35

36 Participant Portal main functions Participant Portal covers: Horizon research and innovation framework programme th research framework programme (FP7) and Competitiveness & Innovation Programme (CIP) Non-registered users may: search for funding read the funding guide & download the legal documents check if an organisation is already registered get the information on expert database contact the support services or check FAQs Registered users may: submit the proposal sign the grant manage their project throughout its lifecycle register as an expert 36

37 Funding opportunities 37

38 How to participate 38

39 Registrationprocess Fill in your address and the security check Follow the instruction given in the received 39

40 PARTICIPANT PORTAL ECAS ACCOUNT 40

41 Obtaining PIC MY ORGANISATION REGISTER START REGISTRATION STEP 1: ECAS account STEP 2: Start the registration of an organization basic legal information (Registration extract, VAT data) of your organization needed STEP 3: Finalize the organization registration and receive a PIC number 41

42 Once logged in 42 42

43 Electronic Submission Service - SEP The electronic proposal submission system: integrated in the Participant Portal the servise is available linked to an open call draft and submitted proposals are accessible under the My Proposals tab Steps for proposal submission Instrument selection Pre-registration Consortium setup Edit proposal &submission Form filling Submission 43

44 44

45 45

46 ONLINE SUBMISSION FORMS PROPOSAL PART A Administrative PART B Technical

47 Two-stages PARTE A Deadlines: Stage-I: 14th October 2014 Stage-II: 24th February 2015 PARTE B 1) General Information 2) Participants & Contacts (only coordinator) 3) Budget (only Total Requested Amount) 1) Excellence 1.1) Objectives 1.2)Relation to the Work Programme 1.3) Concept and Approach 1.4) Ambition 2) Impact 2.1) Expected impacts Template pdf online sul Participant Portal Doc Word scaricabile dal Participant Portal Max. 15 pages! 7 pages in Health 47

48 Single stage (Deadline: 15th April 2014) PARTE A 1) General Information 2) Participants & Contacts 3) Budget 4) Ethics Template pdf online sul Participant Portal PARTE B 1) Excellence 1.1) Objectives 1.2)Relation to the Work Programme 1.3) Concept and Approach 1.4) Ambition 2) Impact 2.1) Expected impacts 2.2) Measures to maximize the impact - Dissemination and exploitation of results - Communication activities 3) Implementation 3.1) Work plan Work packages, deliverables and milestones 3.2) Management structure and procedures 3.3) Consortium as a whole 3.4) Resources to be committed 4) Members of the consortium 4.1) Participants (applicants) 4.2) Third parties involved in the project (including use of third party resources) 5) Ethics and Security Documento Word scaricabile dal Participant Portal Max. 70 pages! (1+2+3) 48

49 1: Excellence 1.1 Objectives Describe the specific objectives for the project, which should be: clear, measurable, realistic and achievable within the duration of the project. Objectives should be consistent with the expected exploitation and impact of the project (see section 2). 49

50 1.2 Relation to the work programme Indicate the work programme topic to which your proposal relates, and explain how your proposal addresses the specific challenge and scope of that topic, as set out in the work programme. 1.3 Concept and approach - Describe and explain the overall concept underpinning the project: main ideas, models or assumptions involved, trans-disciplinary considerations; - Describe the positioning of the project e.g. where it is situated in the spectrum from idea to application, or from lab to market. - Describe any national or international research and innovation activities which will be linked with the project, especially where the outputs from these will feed into the project; - Describe and explain the overall approach and methodology. 50

51 1.4 Ambition - Describe the advance your proposal would provide beyond the state-ofthe-art, and the extent the proposed work is ambitious. - Describe the innovation potential which the proposal represents. Where relevant, refer to products and services already available on the market. Please refer to the results of any patent search carried out. 2. Impact - Describe how your project will contribute to the expected impacts set out in the work programme, under the relevant topic; 51

52 3. Implementation -3.1 Work plan brief presentation of the overall structure of the work plan timing of the different work packages and their components (Gantt chart or similar) detailed work description, i.e.: a description of each work package (table 3.1a) a list of work packages (table 3.1b) a list of major deliverables (table 3.1c) graphical presentation of the components showing how they inter-relate (Pert chart or similar) 52

53 3. Implementation -3.2 Management structure and procedures Describe the organisational structure and the decision-making ( including a list of milestones (table 3.2a)) Explain why the organisational structure and decision-making mechanisms are appropriate to the complexity and scale of the project Describe, where relevant, how effective innovation management will be addressed in the management structure and work plan n.b.1 Innovation management is a process which requires an understanding of both market and technical problems, with a goal of successfully implementing appropriate creative ideas. A new or improved product, service or process is its typical output. It also allows a consortium to respond to an external or internal opportunity Describe any critical risks, relating to project implementation, that the stated project's objectives may not be achieved. Detail any risk mitigation measures. Please provide a table with critical risks identified and mitigating actions (table 3.2b) 53

54 3. Implementation Consortium as a whole Describe the consortium. How will it match the project s objectives? How do the members complement one another (and cover the value chain, where appropriate)? In what way does each of them contribute to the project? How will they be able to work effectively together? If applicable, describe the industrial/commercial involvement in the project to ensure exploitation of the results and explain why this is consistent with and will help to achieve the specific measures which are proposed for exploitation of the results of the project (see section 2.3) Other countries: If one or more of the participants requesting EU funding is based in a country that is not automatically eligible for such funding (entities from Member States of the EU, from Associated Countries and from one of the countries in the exhaustive list included in General Annex A of the work programme are automatically eligible for EU funding), explain why the participation of the entity in question is essential to carrying out the project 54

55 3. Implementation -3.4 Resources to be committed a table showing number of person/months required (table 3.4a) a table showing other direct costs (table 3.4b) for participants where those costs exceed 15% of the personnel costs (according to the budget table in section 3 of the administrative proposal forms) 55

56 4. Members of the consortium a description of the legal entity and its main tasks, with an explanation of how its profile matches the tasks in the proposal a curriculum vitae or description of the profile of the persons, including their gender, who will be primarily responsible for carrying out the proposed research and/or innovation activities a list of up to 5 relevant publications, and/or products, services (including widely-used datasets or software), or other achievements relevant to the call content a list of up to 5 relevant previous projects or activities, connected to the subject of this proposal a description of any significant infrastructure and/or any major items of technical equipment, relevant to the proposed work [any other supporting documents specified in the work programme for this call.] 56

57 4. Members of the consortium Maximum 2 pages Description of the organization Main tasks in the project Previous relevant experiences 2/3 curriculum vitae up to 5 relevant publications up to 5 relevant previous projects any significant infrastructure 57

58 58

59 GRAZIE PER L ATTENZIONE! APRE Agenzia per la Promozione della Ricerca Europea via Cavour, Roma Tel. (+39) Fax. (+39) Bruno Mourenza Health NCP mourenza@apre.it 59